TradingView
JetEquities
Oct 2, 2019 4:25 PM
Heron Announces Positive Topline Results from Phase 3b Clinical
Long
NASDAQ:HRTX
30
Heron Therapeutics, Inc.
NASDAQ
Description
⋅
Oct 2, 2019 4:25 PM
HRTX: Heron Therapeutics, Inc.
2019-10-02 07:45:00
Heron Announces Positive Topline Results from Phase 3b Clinical Study of HTX-011 in Total Knee Arthroplasty
Beyond Technical Analysis
Comments
Dwsilk93
⋅
Jan 23, 2020 5:14 PM
@SonalSignals2018 nice call!
More